JP2010518140A - Ｉｇｆ−１ｒに対する新規抗体 - Google Patents

Ｉｇｆ−１ｒに対する新規抗体 Download PDF

Info

Publication number
JP2010518140A
JP2010518140A JP2009549402A JP2009549402A JP2010518140A JP 2010518140 A JP2010518140 A JP 2010518140A JP 2009549402 A JP2009549402 A JP 2009549402A JP 2009549402 A JP2009549402 A JP 2009549402A JP 2010518140 A JP2010518140 A JP 2010518140A
Authority
JP
Japan
Prior art keywords
antibody
antigen
seq
binding fragment
igf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009549402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010518140A5 (es
Inventor
バーデン，マイケル，ニール
エリス，ジョナサン，ヘンリー
ハンブリン，ポール，アンドリュー
ルイス，アラン，ピーター
シャー，ラドハ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702888.9A external-priority patent/GB0702888D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JP2010518140A publication Critical patent/JP2010518140A/ja
Publication of JP2010518140A5 publication Critical patent/JP2010518140A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
JP2009549402A 2007-02-14 2008-02-12 Ｉｇｆ−１ｒに対する新規抗体 Pending JP2010518140A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0702888.9A GB0702888D0 (en) 2007-02-14 2007-02-14 Novel Antibodies
US95321007P 2007-08-01 2007-08-01
PCT/EP2008/051655 WO2008098917A2 (en) 2007-02-14 2008-02-12 Novel antibodies against igf-ir

Publications (2)

Publication Number Publication Date
JP2010518140A true JP2010518140A (ja) 2010-05-27
JP2010518140A5 JP2010518140A5 (es) 2010-09-30

Family

ID=42025950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009549402A Pending JP2010518140A (ja) 2007-02-14 2008-02-12 Ｉｇｆ−１ｒに対する新規抗体

Country Status (5)

Country Link
JP (1) JP2010518140A (es)
KR (1) KR20090114449A (es)
EA (1) EA200900991A1 (es)
MX (1) MX2009008754A (es)
PE (1) PE20090107A1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015505843A (ja) * 2011-12-15 2015-02-26 ザ・ロイヤル・インスティテューション・フォア・ザ・アドバンスメント・オブ・ラーニング／マクギル・ユニヴァーシティ 可溶性ＩＧＦレセプターＦｃ融合タンパク質およびその使用
JP2019501631A (ja) * 2015-10-23 2019-01-24 アポジェニックス アーゲー 一本鎖ｇｉｔｒ受容体アゴニストタンパク質

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3027824A1 (en) 2010-02-23 2011-09-01 Sanofi Anti-alpha2 integrin antibodies and their uses
TWI560199B (en) 2010-08-31 2016-12-01 Sanofi Sa Peptide or peptide complex binding to α2 integrin and methods and uses involving the same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053596A2 (en) * 2001-01-05 2002-07-11 Pfizer Inc. Antibodies to insulin-like growth factor i receptor
WO2003106621A2 (en) * 2002-06-14 2003-12-24 Immunogen, Inc. Anti-igf-i receptor antibody
WO2005016970A2 (en) * 2003-05-01 2005-02-24 Imclone Systems Incorporated Fully human antibodies directed against the human insulin-like growth factor-1 receptor
WO2005058967A2 (en) * 2003-12-16 2005-06-30 Pierre Fabre Medicament Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
WO2005061541A1 (en) * 2002-06-14 2005-07-07 Immunogen, Inc. Anti-igf-i receptor antibody
WO2006013472A2 (en) * 2004-07-29 2006-02-09 Pierre Fabre Medicament Novel anti-igf-ir antibodies and uses thereof
WO2007000328A1 (en) * 2005-06-27 2007-01-04 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
WO2007012614A2 (en) * 2005-07-22 2007-02-01 Pierre Fabre Medicament Novel anti-igf-ir antibodies and uses thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053596A2 (en) * 2001-01-05 2002-07-11 Pfizer Inc. Antibodies to insulin-like growth factor i receptor
WO2003106621A2 (en) * 2002-06-14 2003-12-24 Immunogen, Inc. Anti-igf-i receptor antibody
WO2005061541A1 (en) * 2002-06-14 2005-07-07 Immunogen, Inc. Anti-igf-i receptor antibody
WO2005016970A2 (en) * 2003-05-01 2005-02-24 Imclone Systems Incorporated Fully human antibodies directed against the human insulin-like growth factor-1 receptor
WO2005058967A2 (en) * 2003-12-16 2005-06-30 Pierre Fabre Medicament Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
WO2006013472A2 (en) * 2004-07-29 2006-02-09 Pierre Fabre Medicament Novel anti-igf-ir antibodies and uses thereof
WO2007000328A1 (en) * 2005-06-27 2007-01-04 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
WO2007012614A2 (en) * 2005-07-22 2007-02-01 Pierre Fabre Medicament Novel anti-igf-ir antibodies and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015505843A (ja) * 2011-12-15 2015-02-26 ザ・ロイヤル・インスティテューション・フォア・ザ・アドバンスメント・オブ・ラーニング／マクギル・ユニヴァーシティ 可溶性ＩＧＦレセプターＦｃ融合タンパク質およびその使用
JP2019501631A (ja) * 2015-10-23 2019-01-24 アポジェニックス アーゲー 一本鎖ｇｉｔｒ受容体アゴニストタンパク質

Also Published As

Publication number Publication date
MX2009008754A (es) 2009-11-02
EA200900991A1 (ru) 2010-02-26
KR20090114449A (ko) 2009-11-03
PE20090107A1 (es) 2009-03-20

Similar Documents

Publication Publication Date Title
US20100047243A1 (en) Novel antibodies against igf-ir
AU2007233831B2 (en) Antibodies against amyloid-beta peptide
JP2010534710A (ja) 新規抗体
JP5850860B2 (ja) Ｃｄ１２７結合タンパク質
CN113480656B (zh) 抗ror1抗体
KR20160127825A (ko) 항-mcam 항체 및 관련된 사용 방법
KR20160131061A (ko) 항-mcam 항체 및 관련된 사용 방법
CN114728065A (zh) 针对cd3和bcma的抗体和自其制备的双特异性结合蛋白
JP2022516881A (ja) 抗ｃｔｌａ４抗体およびその使用方法
JP2010518140A (ja) Ｉｇｆ−１ｒに対する新規抗体
WO2021129672A1 (en) Novel anti-fgfr2b antibodies
CA3160811A1 (en) Novel anti-fgfr2b antibodies
CA3160810A1 (en) Novel anti-fgfr2b antibodies
WO2024089551A1 (en) Msln and cd3 binding agents and methods of use thereof
TW202317612A (zh) 用於治療癌症的ｃｔｌａ４及ｐｄ１／ｐｄｌ１抗體之組合

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100727

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120207

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120626